LigaChem Biosciences Future Growth
Future criteria checks 2/6
LigaChem Biosciences's earnings are forecast to decline at 16.5% per annum while its annual revenue is expected to grow at 20.6% per year. EPS is expected to decline by 5% per annum. Return on equity is forecast to be -21.7% in 3 years.
Key information
-16.5%
Earnings growth rate
-5.0%
EPS growth rate
| Life Sciences earnings growth | 25.0% |
| Revenue growth rate | 20.6% |
| Future return on equity | -21.7% |
| Analyst coverage | Low |
| Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money
May 23
A Look At The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)
Mar 29What Kind Of Shareholders Hold The Majority In LegoChem Biosciences, Inc.'s (KOSDAQ:141080) Shares?
Jan 28Estimating The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)
Dec 07
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 126,000 | -60,000 | -50,000 | -56,000 | 1 |
| 12/31/2025 | 73,000 | -70,500 | -70,500 | -66,500 | 2 |
| 12/31/2024 | 96,000 | -36,000 | -31,000 | -34,000 | 1 |
| 3/31/2024 | 57,543 | -46,543 | 61,223 | 63,270 | N/A |
| 12/31/2023 | 34,146 | -73,704 | -64,438 | -62,236 | N/A |
| 9/30/2023 | 34,470 | -83,053 | -51,935 | -50,483 | N/A |
| 6/30/2023 | 35,643 | -71,784 | -31,067 | -29,782 | N/A |
| 3/31/2023 | 35,266 | -54,336 | -31,871 | -28,402 | N/A |
| 12/31/2022 | 33,412 | -45,092 | -11,908 | -7,136 | N/A |
| 9/30/2022 | 41,783 | -5,173 | -23,071 | -13,416 | N/A |
| 6/30/2022 | 39,789 | -5,443 | -47,026 | -29,862 | N/A |
| 12/31/2021 | 32,157 | -23,391 | -60,493 | -42,049 | N/A |
| 12/31/2019 | 57,500 | 13,586 | 20,626 | 24,113 | N/A |
| 9/30/2019 | 51,280 | -1,073 | 11,844 | 15,351 | N/A |
| 6/30/2019 | 29,947 | -24,220 | -14,347 | -11,102 | N/A |
| 3/31/2019 | 28,452 | -23,197 | -15,196 | -12,802 | N/A |
| 12/31/2018 | 25,240 | -25,770 | -16,728 | -12,758 | N/A |
| 9/30/2018 | 24,869 | -15,221 | -18,020 | -14,049 | N/A |
| 6/30/2018 | 23,907 | -10,598 | -4,797 | -301 | N/A |
| 3/31/2018 | 23,177 | -12,034 | -11,676 | -7,192 | N/A |
| 12/31/2017 | 22,057 | -12,934 | N/A | -8,213 | N/A |
| 9/30/2017 | 20,790 | -15,746 | N/A | -7,222 | N/A |
| 6/30/2017 | 18,845 | -15,890 | N/A | -18,216 | N/A |
| 3/31/2017 | 17,541 | -16,183 | N/A | -11,895 | N/A |
| 12/31/2016 | 16,655 | -14,725 | N/A | -13,039 | N/A |
| 9/30/2016 | 13,720 | -8,330 | N/A | -10,609 | N/A |
| 6/30/2016 | 10,294 | -8,192 | N/A | -9,457 | N/A |
| 3/31/2016 | 6,295 | -7,671 | N/A | -9,535 | N/A |
| 12/31/2015 | 1,788 | -8,237 | N/A | -8,780 | N/A |
| 12/31/2014 | 870 | -8,686 | N/A | -7,882 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A141080 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: A141080 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: A141080 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: A141080's revenue (20.6% per year) is forecast to grow faster than the KR market (10.1% per year).
High Growth Revenue: A141080's revenue (20.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A141080 is forecast to be unprofitable in 3 years.